Anne K. Mylin

1.5k total citations
16 papers, 531 citations indexed

About

Anne K. Mylin is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Anne K. Mylin has authored 16 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Hematology. Recurrent topics in Anne K. Mylin's work include Multiple Myeloma Research and Treatments (6 papers), Peptidase Inhibition and Analysis (5 papers) and Studies on Chitinases and Chitosanases (5 papers). Anne K. Mylin is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Peptidase Inhibition and Analysis (5 papers) and Studies on Chitinases and Chitosanases (5 papers). Anne K. Mylin collaborates with scholars based in Denmark, Norway and Sweden. Anne K. Mylin's co-authors include Julia S. Johansen, Ingemar Turesson, Stig E. Bojesen, Paul A. Price, Børge G. Nordestgaard, Anders Waage, Toril Holien, Oddrun Elise Olsen, Karin Fahl Wader and Anders Sundan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Anne K. Mylin

16 papers receiving 526 citations

Peers

Anne K. Mylin

ONCOL

RHEUM

IMMUN

HEMAT

Anna Mansour France

Satoshi Hamanoue Japan

Maria Spyropoulou‐Vlachou Greece

Rikke Riisbro Denmark

M Masi Italy

Ali Tabarroki United States

Yoshitaka Kinoshita Japan

Michele Vigolo Switzerland

M Togashi Japan

H van Kamp Netherlands

Anna Mansour France

Anne K. Mylin

266 ×0.7

155 ×0.9

ONCOL

51 ×0.6

RHEUM

151 ×1.8

IMMUN

154 ×2.7

HEMAT

Citations per year, relative to Anne K. Mylin Anne K. Mylin (= 1×) peers Anna Mansour

Countries citing papers authored by Anne K. Mylin

Since Specialization

Citations

This map shows the geographic impact of Anne K. Mylin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne K. Mylin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne K. Mylin more than expected).

Fields of papers citing papers by Anne K. Mylin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne K. Mylin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne K. Mylin. The network helps show where Anne K. Mylin may publish in the future.

Co-authorship network of co-authors of Anne K. Mylin

This figure shows the co-authorship network connecting the top 25 collaborators of Anne K. Mylin. A scholar is included among the top collaborators of Anne K. Mylin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne K. Mylin. Anne K. Mylin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Nielsen, Lene Kongsgaard, Rebecca Mercieca‐Bebber, Sören Möller, et al.. (2024). Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms. Quality of Life Research. 33(9). 2387–2400. 1 indexed citations

Sørensen, Jonas, et al.. (2022). Early, Patient-Centered, and Multidisciplinary Approach in Newly Diagnosed Multiple Myeloma: What Are We Talking About? A Case Description and Discussion. SHILAP Revista de lepidopterología. 3(1). 369–373. 2 indexed citations

Fosbøl, Emil Loldrup, Matthew J. Maurer, Philip Hasbak, et al.. (2022). Screening for Cardiac Amyloidosis 5 to 15 Years After Surgery for Bilateral Carpal Tunnel Syndrome. Journal of the American College of Cardiology. 80(10). 967–977. 49 indexed citations

Nielsen, Lene Kongsgaard, Madeleine King, Sören Möller, et al.. (2019). Strategies to improve patient-reported outcome completion rates in longitudinal studies. Quality of Life Research. 29(2). 335–346. 28 indexed citations

Westhrin, Marita, Siv Helen Moen, Ida Bruun Kristensen, et al.. (2018). Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes. Biomarker Research. 6(1). 21–21. 15 indexed citations

Olsen, Oddrun Elise, Karin Fahl Wader, Hanne Hella, et al.. (2015). Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B. Cell Communication and Signaling. 13(1). 27–27. 124 indexed citations

Mylin, Anne K., Niels Abildgaard, Julia S. Johansen, et al.. (2015). Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma. Leukemia & lymphoma. 56(9). 2650–2659. 18 indexed citations

Mylin, Anne K., Jens P. Goetze, Lene Heickendorff, et al.. (2015). N-Terminal Pro-C-Type Natriuretic Peptide in Serum Associated With Bone Destruction in Patients With Multiple Myeloma. Biomarkers in Medicine. 9(7). 679–689. 6 indexed citations

Olsen, Oddrun Elise, Karin Fahl Wader, Kristine Misund, et al.. (2014). Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin. Blood Cancer Journal. 4(3). e196–e196. 40 indexed citations

10.

Johnsen, Hans Erik, Martin Bøgsted, Tobias Wirenfeldt Klausen, et al.. (2010). Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma. Cytometry Part B Clinical Cytometry. 78B(5). 338–347. 19 indexed citations

11.

Johansen, Julia S., Stig E. Bojesen, Anne Tybjærg‐Hansen, et al.. (2010). Plasma YKL-40 and Total and Disease-Specific Mortality in the General Population. Clinical Chemistry. 56(10). 1580–1591. 52 indexed citations

12.

Johnsen, Hans Erik, Lene Meldgaard Knudsen, Anne K. Mylin, et al.. (2009). Up-front fludarabine impairs stem cell harvest in multiple myeloma: report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial. Hematology Reports. 1(2). 11–11. 1 indexed citations

13.

Johansen, Julia S., Stig E. Bojesen, Anne K. Mylin, et al.. (2008). Elevated Plasma YKL-40 Predicts Increased Risk of Gastrointestinal Cancer and Decreased Survival After Any Cancer Diagnosis in the General Population. Journal of Clinical Oncology. 27(4). 572–578. 73 indexed citations

14.

Mylin, Anne K., Niels Abildgaard, Julia S. Johansen, et al.. (2007). High serum YKL‐40 concentration is associated with severe bone disease in newly diagnosed multiple myeloma patients. European Journal Of Haematology. 80(4). 310–317. 16 indexed citations

15.

Mylin, Anne K., Thomas Rasmussen, Julia S. Johansen, et al.. (2006). Serum YKL‐40 concentrations in newly diagnosed multiple myeloma patients and YKL‐40 expression in malignant plasma cells. European Journal Of Haematology. 77(5). 416–424. 22 indexed citations

16.

Bergmann, Olav J., Julia S. Johansen, Tobias Wirenfeldt Klausen, et al.. (2005). High Serum Concentration of YKL-40 Is Associated with Short Survival in Patients with Acute Myeloid Leukemia. Clinical Cancer Research. 11(24). 8644–8652. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact